Gene · 54600
Papers2,066
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,066
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications. | Clin Transl Sci | 2026 | 41635062 | PubTator, text mining | PubMed |
| High Risk of Drug-Drug Interactions Caused by Pexidartinib via UDP-Glucuronosyltransferases Inhibition. | Chem Res Toxicol | 2026 | 41575265 | PubTator, text mining | PubMed |
| Retrospection of the USFDA-Approved Halogenated Drugs and Their Implication in Medicinal Chemistry and Drug Discovery: A Perspective of Approved Drugs Between 2019 and 2024. | Arch Pharm (Weinheim) | 2026 | 41556324 | PubTator, text mining | PubMed |
| Pharmacogenomics of commonly used intravenous anesthetics. | Pharmacogenet Genomics | 2026 | 41437621 | PubTator, text mining | PubMed |
| UDP-glucuronosyltransferase 1A9 function is mediated by the two C-terminal lysine residues and proper mobility/flexibility of the cytoplasmic tail. | Biochem Biophys Res Commun | 2026 | 41317709 | PubTator, text mining | PubMed |
| MetabFlow: a comprehensive metabolic map for exogenous natural products. | Nucleic Acids Res | 2026 | 41312638 | PubTator, text mining | PubMed |
| Characterization of In Vitro metabolic profiles of crepidatin in human liver microsomes and hepatocytes using HPLC-MS/MS and HPLC-Q-Orbitrap-HRMS. | J Pharm Biomed Anal | 2026 | 41270311 | PubTator, text mining | PubMed |
| In-silico identification of a Doxorubicin alternative with reduced cardiotoxicity informed by LLM-assisted modeling. | J Mol Graph Model | 2026 | 41223606 | PubTator, text mining | PubMed |
| Association of UGT1A9 Polymorphisms with Cardiac Injury Biomarkers and Clinical Features. | Pharmaceuticals (Basel) | 2025 | 41599675 | PubTator, text mining | PubMed |
| Exploring the Population Pharmacokinetic and Pharmacogenetics Characteristics of Flurbiprofen Isomers in Selective Joint Replacement Patients with Postoperative Pain. | Drug Des Devel Ther | 2025 | 41090024 | PubTator, text mining | PubMed |
| Association of genetic variation with irinotecan infusion reactions and severe toxicity. | Pharmacogenet Genomics | 2025 | 40900652 | PubTator, text mining | PubMed |
| Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series. | Nat Commun | 2025 | 40897730 | PubTator, text mining | PubMed |
| From laboratory to clinic: opportunities and challenges of functional food active ingredients in cancer therapy. | Front Nutr | 2025 | 40808836 | PubTator, text mining | PubMed |
| Impact of genetic variations on the pharmacokinetics, dose requirements, and clinical effects of propofol: a systematic review. | Br J Anaesth | 2025 | 40769841 | PubTator, text mining | PubMed |
| Pharmacogenetics association with long-term clinical evolution in a kidney transplant patients cohort. | Curr Res Pharmacol Drug Discov | 2025 | 40761554 | PubTator, text mining | PubMed |
| Dapagliflozin-Associated Hepatotoxicity With a Positive Rechallenge. | ACG Case Rep J | 2025 | 40761328 | PubTator, text mining | PubMed |
| Regorafenib versus local standard of care in patients with grade 2-3 meningioma no longer eligible for loco-regional treatments: a phase II randomized controlled trial (the MIRAGE study). | Trials | 2025 | 40759981 | PubTator, text mining | PubMed |
| Artesunate regulates malignant progression of breast cancer cells via lncRNA TUG1/miR-145-5p/HOXA5 axis. | PLoS One | 2025 | 40758729 | PubTator, text mining | PubMed |
| CYP2B6*6 single nucleotide polymorphism among patients with uncomplicated malaria in Adjumani district, Uganda: Implications on efficacy of artemether-lumefantrine. | PLoS One | 2025 | 40748991 | PubTator, text mining | PubMed |
| Pharmacokinetics of Bocidelpar, ASP0367, in Renal and Hepatic Impairment: Results From Two Phase 1 Studies. | Clin Transl Sci | 2025 | 40748778 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54600/papers?page=2